Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Head

Showing results (311-320 of 364) with videos related to

Pageof 37
Sort By:
Biorxiv : the Preprint Server for Biology|August 7, 2023
Spatial and single-nucleus transcriptomic analysis of genetic and sporadic forms of Alzheimer's DiseaseEmily Miyoshi, Samuel Morabito, Caden M Henningfield, et al.
Neurobiology of Aging|November 15, 2024
Calcineurin/NFAT inhibitors maintain cognition in a preclinical prevention study in an aging canine model of Alzheimer diseaseLorena Sordo, Margo F Ubele, Kathy A Boaz, et al.
Journal of Alzheimer'S Disease : JAD|December 18, 2020
Plasma Total-Tau and Neurofilament Light Chain as Diagnostic Biomarkers of Alzheimer's Disease Dementia and Mild Cognitive Impairment in Adults with Down SyndromeMelissa E Petersen, Michael S Rafii, Fan Zhang, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 15, 2025
The Alzheimer's Biomarker Consortium-Down Syndrome (ABC-DS): A 10-year reportBenjamin L Handen, Mark Mapstone, Sigan Hartley, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 7, 2025
The striatum is an early, accurate indicator of amyloid burden using [<sup>11</sup>C]PiB in Down syndrome: Comparison of two radiotracersMax McLachlan, Brecca Bettcher, Andrew McVea, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 25, 2022
Probing the proteome to explore potential correlates of increased Alzheimer's-related cerebrovascular disease in adults with Down syndromeFahmida Moni, Melissa E Petersen, Fan Zhang, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|April 16, 2024
Cognitive and functional performance and plasma biomarkers of early Alzheimer's disease in Down syndromeEmily K Schworer, Benjamin L Handen, Melissa Petersen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 3, 2017
Cerebral amyloid angiopathy in Down syndrome and sporadic and autosomal-dominant Alzheimer's diseaseMaría Carmona-Iragui, Mircea Balasa, Bessy Benejam, et al.
Nature Genetics|November 23, 2024
Spatial and single-nucleus transcriptomic analysis of genetic and sporadic forms of Alzheimer's diseaseEmily Miyoshi, Samuel Morabito, Caden M Henningfield, et al.
The Lancet. Neurology|July 24, 2021
Diagnostic and prognostic performance and longitudinal changes in plasma neurofilament light chain concentrations in adults with Down syndrome: a cohort studyMaria Carmona-Iragui, Daniel Alcolea, Isabel Barroeta, et al.
Pageof 37

Showing results (311-320 of 364) with videos related to

Sort By:
Pageof 37
Biorxiv : the Preprint Server for Biology|August 7, 2023
Spatial and single-nucleus transcriptomic analysis of genetic and sporadic forms of Alzheimer's DiseaseEmily Miyoshi, Samuel Morabito, Caden M Henningfield, et al.
Neurobiology of Aging|November 15, 2024
Calcineurin/NFAT inhibitors maintain cognition in a preclinical prevention study in an aging canine model of Alzheimer diseaseLorena Sordo, Margo F Ubele, Kathy A Boaz, et al.
Journal of Alzheimer'S Disease : JAD|December 18, 2020
Plasma Total-Tau and Neurofilament Light Chain as Diagnostic Biomarkers of Alzheimer's Disease Dementia and Mild Cognitive Impairment in Adults with Down SyndromeMelissa E Petersen, Michael S Rafii, Fan Zhang, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 15, 2025
The Alzheimer's Biomarker Consortium-Down Syndrome (ABC-DS): A 10-year reportBenjamin L Handen, Mark Mapstone, Sigan Hartley, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 7, 2025
The striatum is an early, accurate indicator of amyloid burden using [<sup>11</sup>C]PiB in Down syndrome: Comparison of two radiotracersMax McLachlan, Brecca Bettcher, Andrew McVea, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 25, 2022
Probing the proteome to explore potential correlates of increased Alzheimer's-related cerebrovascular disease in adults with Down syndromeFahmida Moni, Melissa E Petersen, Fan Zhang, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|April 16, 2024
Cognitive and functional performance and plasma biomarkers of early Alzheimer's disease in Down syndromeEmily K Schworer, Benjamin L Handen, Melissa Petersen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 3, 2017
Cerebral amyloid angiopathy in Down syndrome and sporadic and autosomal-dominant Alzheimer's diseaseMaría Carmona-Iragui, Mircea Balasa, Bessy Benejam, et al.
Nature Genetics|November 23, 2024
Spatial and single-nucleus transcriptomic analysis of genetic and sporadic forms of Alzheimer's diseaseEmily Miyoshi, Samuel Morabito, Caden M Henningfield, et al.
The Lancet. Neurology|July 24, 2021
Diagnostic and prognostic performance and longitudinal changes in plasma neurofilament light chain concentrations in adults with Down syndrome: a cohort studyMaria Carmona-Iragui, Daniel Alcolea, Isabel Barroeta, et al.
Pageof 37